KP Tissue (KPT) Stock Price, News & Analysis

Company Overview

KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.

Key Stats

• Today's Range: C$13.06 to C$13.20
• 50-Day Range: C$11.32 to C$13.61
• 52-Week Range: C$8.73 to C$13.78
• Volume: 16,152 shs
• Average Volume: 15,826 shs
• Market Capitalization: C$132.37 million
• P/E Ratio: 14.67
• Dividend Yield: 5.45%
• Price Target: C$11.63
• Consensus Rating: Hold

KP Tissue Stock Analysis - MarketRank™

KP Tissue scored higher than 20% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.4 / 5
• Analyst Rating: Hold

Consensus Rating

KP Tissue has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 3 hold ratings, and no sell ratings.

Downside Risk

KP Tissue has a consensus price target of C$11.63, representing about 11.9% downside from its current price of C$13.20.

Amount of Analyst Coverage

KP Tissue has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of KP Tissue is 14.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.96.

Price to Earnings Ratio vs. Sector

The P/E ratio of KP Tissue is 14.67, which means that it is trading at a less expensive P/E ratio than the Consumer Defensive sector average P/E ratio of about 891.54.

Price to Earnings Growth Ratio

Due to a projected decrease in earnings for KP Tissue, their PEG ratio cannot be calculated.

Price to Book Value per Share Ratio

KP Tissue has a P/B Ratio of 1.86. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for KPT.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

KP Tissue is a leading dividend payer. It pays a dividend yield of 6.39%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

KP Tissue does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of KP Tissue is 80.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

1 people have added KP Tissue to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, KP Tissue insiders have sold more of their company's stock than they have bought. Specifically, they have bought C$0.00 in company stock and sold C$87,644.00 in company stock.

Percentage Held by Insiders

0.14% of the stock of KP Tissue is held by insiders.

Percentage Held by Institutions

1.35% of the stock of KP Tissue is held by institutions.

Company Calendar

• Last Earnings: 5/14/2026
• Ex-Dividend for 7/15 Dividend: 6/30/2026
• Today: 7/09/2026
• Record date for 7/15 Dividend: 7/15/2026
• Dividend Payable: 7/15/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Consumer Defensive
• Industry: Household & Personal Products
• Sub-Industry: N/A
• Current Symbol: TSE:KPT
• CIK: N/A
• Web: kptissueinc.com
• Phone: +1-905-8126900
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for KP Tissue: C$11.63
• High Price Target: C$12.50
• Low Price Target: C$11.00
• Potential Upside/Downside: -11.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): C$0.90
• Trailing P/E Ratio: 14.67
• Forward P/E Ratio: 30.01
• P/E Growth: -0.88
• Net Income: C$6.38 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: 12.81%
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.00
• Quick Ratio: 1.23

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$7.09 per share
• Price / Book: 1.86

Miscellaneous

• Outstanding Shares: 10,028,000
• Free Float: N/A
• Market Cap: C$132.37 million
• Optionable: Not Optionable
• Beta: 0.53